Orbem has developed a proprietary MRI platform combined with artificial intelligence that can scan biological items in under one second without human intervention, allowing industrial-scale, non-invasive quality assessment. In the poultry sector, the system has already analyzed more than 170 million eggs, offering an alternative to chick culling and improving sustainability. The company is now broadening its “Vertical AI” capabilities to fruit and vegetable inspection, enabling producers to detect internal defects in items like avocados and mangoes without cutting them open. Beyond food, Orbem aims to ‘industrialize MRI’ for human healthcare and is assembling what it calls the world’s largest biological imaging dataset to unlock new medical insights. Fresh capital will support global expansion, with priority given to the U.S. market via a new Houston office, while continuing product development. Orbem claims to be the first—and so far only—company to demonstrate MRI at this speed and scale, positioning itself as a leader in fast, automated biological imaging.

Total raised

$97M

Funding rounds

2

Latest round

Series B

Latest activity

Jan 2026